| CAS NO: | 189224-26-8 |
| 包装 | 价格(元) |
| Free Sample (0.1-0.5mg) | 电议 |
| 5mg | 电议 |
| 10mM (in 1mL Water) | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| Cas No. | 189224-26-8 |
| 别名 | 奥扎格雷钠; OKY-046 sodium |
| Canonical SMILES | O=C([O-])/C=C/C1=CC=C(CN2C=CN=C2)C=C1.[Na+] |
| 分子式 | C13H11N2NaO2 |
| 分子量 | 250.23 |
| 溶解度 | Water: ≥ 44 mg/mL (175.84 mM) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Ozagrel sodium (OKY-046 sodium) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor. Thromboxane A2 Synthase [1]. Nakazawa, M., et al., [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase]. Yakugaku Zasshi, 1994. 114(12): p. 911-33. [2]. Li, S.B., et al., In vitro effect of ozagrel on mushroom tyrosinase. Protein J, 2009. 28(3-4): p. 182-8. [3]. Westphal, M., et al., Selective thromboxane A2 synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injury. Anesthesiology, 2005. 102(5): p. 954-61. |
m.cnreagent.com